IMRX
Price
$4.06
Change
+$0.06 (+1.50%)
Updated
Jul 25 closing price
Capitalization
146.1M
10 days until earnings call
RNXT
Price
$1.27
Change
-$0.03 (-2.31%)
Updated
Jul 25 closing price
Capitalization
46.45M
18 days until earnings call
Interact to see
Advertisement

IMRX vs RNXT

Header iconIMRX vs RNXT Comparison
Open Charts IMRX vs RNXTBanner chart's image
Immuneering
Price$4.06
Change+$0.06 (+1.50%)
Volume$212.05K
Capitalization146.1M
RenovoRx
Price$1.27
Change-$0.03 (-2.31%)
Volume$51.37K
Capitalization46.45M
IMRX vs RNXT Comparison Chart in %
Loading...
IMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNXT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMRX vs. RNXT commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMRX is a Hold and RNXT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (IMRX: $4.06 vs. RNXT: $1.27)
Brand notoriety: IMRX and RNXT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMRX: 13% vs. RNXT: 32%
Market capitalization -- IMRX: $146.1M vs. RNXT: $46.45M
IMRX [@Biotechnology] is valued at $146.1M. RNXT’s [@Biotechnology] market capitalization is $46.45M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMRX’s FA Score shows that 0 FA rating(s) are green whileRNXT’s FA Score has 0 green FA rating(s).

  • IMRX’s FA Score: 0 green, 5 red.
  • RNXT’s FA Score: 0 green, 5 red.
According to our system of comparison, IMRX is a better buy in the long-term than RNXT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMRX’s TA Score shows that 4 TA indicator(s) are bullish while RNXT’s TA Score has 4 bullish TA indicator(s).

  • IMRX’s TA Score: 4 bullish, 5 bearish.
  • RNXT’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both IMRX and RNXT are a bad buy in the short-term.

Price Growth

IMRX (@Biotechnology) experienced а -1.69% price change this week, while RNXT (@Biotechnology) price change was -2.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.60%. For the same industry, the average monthly price growth was +17.32%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

IMRX is expected to report earnings on Aug 06, 2025.

RNXT is expected to report earnings on Aug 14, 2025.

Industries' Descriptions

@Biotechnology (+7.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMRX($146M) has a higher market cap than RNXT($46.4M). IMRX YTD gains are higher at: 84.545 vs. RNXT (-1.550). RNXT has higher annual earnings (EBITDA): -11.6M vs. IMRX (-63.85M). IMRX has more cash in the bank: 35.9M vs. RNXT (14.6M). RNXT has less debt than IMRX: RNXT (283K) vs IMRX (4.08M). RNXT has higher revenues than IMRX: RNXT (240K) vs IMRX (0).
IMRXRNXTIMRX / RNXT
Capitalization146M46.4M315%
EBITDA-63.85M-11.6M550%
Gain YTD84.545-1.550-5,453%
P/E RatioN/AN/A-
Revenue0240K-
Total Cash35.9M14.6M246%
Total Debt4.08M283K1,443%
TECHNICAL ANALYSIS
Technical Analysis
IMRXRNXT
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 26 days ago
87%
Bullish Trend 18 days ago
86%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 25 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
IMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNXT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NOVT127.212.04
+1.63%
Novanta
VRE14.670.09
+0.62%
Veris Residential
INTU785.954.74
+0.61%
Intuit
ACNB42.710.04
+0.09%
ACNB Corp
ICMB2.85-0.02
-0.70%
Investcorp Credit Management BDC

IMRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMRX has been loosely correlated with NUVL. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if IMRX jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMRX
1D Price
Change %
IMRX100%
+1.50%
NUVL - IMRX
35%
Loosely correlated
-0.82%
SRRK - IMRX
31%
Poorly correlated
N/A
ENTBF - IMRX
31%
Poorly correlated
N/A
INSM - IMRX
30%
Poorly correlated
+0.42%
DNA - IMRX
29%
Poorly correlated
-6.31%
More

RNXT and

Correlation & Price change

A.I.dvisor tells us that RNXT and TARA have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RNXT and TARA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RNXT
1D Price
Change %
RNXT100%
-2.31%
TARA - RNXT
30%
Poorly correlated
-0.30%
IMRX - RNXT
27%
Poorly correlated
+1.50%
ARQT - RNXT
25%
Poorly correlated
-1.07%
VANI - RNXT
25%
Poorly correlated
+0.62%
CYTK - RNXT
24%
Poorly correlated
-0.35%
More